- Home
- FDBC vs VNDA Comparison
FDBC vs VNDA Comparison
Compare FDBC & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDBC
- VNDA
- Stock Information
- Founded
- FDBC 1902
- VNDA 2002
- Country
- FDBC United States
- VNDA United States
- Employees
- FDBC N/A
- VNDA N/A
- Industry
- FDBC Major Banks
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- FDBC Finance
- VNDA Health Care
- Exchange
- FDBC Nasdaq
- VNDA Nasdaq
- Market Cap
- FDBC 230.4M
- VNDA 237.9M
- IPO Year
- FDBC N/A
- VNDA 2006
- Fundamental
- Price
- FDBC $38.73
- VNDA $4.33
- Analyst Decision
- FDBC
- VNDA Strong Buy
- Analyst Count
- FDBC 0
- VNDA 2
- Target Price
- FDBC N/A
- VNDA $16.50
- AVG Volume (30 Days)
- FDBC 7.2K
- VNDA 754.6K
- Earning Date
- FDBC 04-28-2025
- VNDA 05-07-2025
- Dividend Yield
- FDBC 4.16%
- VNDA N/A
- EPS Growth
- FDBC 12.85
- VNDA N/A
- EPS
- FDBC 3.60
- VNDA N/A
- Revenue
- FDBC $79,425,000.00
- VNDA $198,772,000.00
- Revenue This Year
- FDBC N/A
- VNDA $14.36
- Revenue Next Year
- FDBC N/A
- VNDA $44.53
- P/E Ratio
- FDBC $10.76
- VNDA N/A
- Revenue Growth
- FDBC 9.79
- VNDA 3.18
- 52 Week Low
- FDBC $37.46
- VNDA $3.85
- 52 Week High
- FDBC $61.21
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- FDBC 39.51
- VNDA 43.42
- Support Level
- FDBC $38.42
- VNDA $4.27
- Resistance Level
- FDBC $42.14
- VNDA $4.46
- Average True Range (ATR)
- FDBC 1.39
- VNDA 0.22
- MACD
- FDBC -0.27
- VNDA 0.01
- Stochastic Oscillator
- FDBC 23.65
- VNDA 54.55
About FDBC Fidelity D & D Bancorp Inc.
Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers. Company includes segments: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.